HSIT.F Stock Overview
HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
HBL - Hadasit Bio-Holdings Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₪0.25 |
52 Week High | ₪0.35 |
52 Week Low | ₪0.0003 |
Beta | 0.78 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | -87.15% |
5 Year Change | n/a |
Change since IPO | -83.87% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
HSIT.F | US Biotechs | US Market | |
---|---|---|---|
7D | 0% | -0.5% | 0.6% |
1Y | n/a | 9.6% | 29.5% |
Return vs Industry: Insufficient data to determine how HSIT.F performed against the US Biotechs industry.
Return vs Market: Insufficient data to determine how HSIT.F performed against the US Market.
Price Volatility
HSIT.F volatility | |
---|---|
HSIT.F Average Weekly Movement | n/a |
Biotechs Industry Average Movement | 11.5% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: HSIT.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine HSIT.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 2 | Yoram Azulai | https://www.hbl.co.il |
HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It operates in the fields of oncology, regenerative medicine, and inflammatory disease. The company develops biological drugs; and plasma RNA biomarkers for colorectal cancer.
HBL - Hadasit Bio-Holdings Ltd Fundamentals Summary
HSIT.F fundamental statistics | |
---|---|
Market cap | US$1.75m |
Earnings (TTM) | -US$7.59m |
Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.2x
P/E RatioIs HSIT.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HSIT.F income statement (TTM) | |
---|---|
Revenue | ₪0 |
Cost of Revenue | ₪0 |
Gross Profit | ₪0 |
Other Expenses | ₪29.30m |
Earnings | -₪29.30m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -2.64 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 29.3% |
How did HSIT.F perform over the long term?
See historical performance and comparison